05192013Headline:

GenomeDx to Present Validation and Utility Data on Decipher™ Test for Prostate Cancer at ASCO Genitourinary Cancers Symposium

SAN DIEGO, Feb. 8, 2013 /PRNewswire/ — GenomeDx Biosciences today announced that four posters highlighting the performance and clinical utility of its Decipher™ test will be presented at the 2013 American Society of Clinical Oncology Genitourinary Cancers Symposium…
PR Newswire: Health

What Next?

Related Articles

Powered by Yahoo! Answers

Switch to our mobile site